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Abstract 
ŵĂũŽƌŚĂůůŵĂƌŬŽĨůǌŚĞŝŵĞƌ ?ƐĚŝƐĞĂƐĞŝƐƚŚĞŵŝƐĨŽůĚŝŶŐĂŶĚaggregation of the amyloid-E peptide 
(AE). While early research pointed towards large fibrillar- and plaque-like aggregates as being the most 
toxic species, recent evidence now implicates small soluble AE oligomers as being orders of magnitude 
more harmful. Techniques capable of characterizing oligomer stoichiometry and assembly are thus 
critical for a deeper understanding of the earliest stages of neurodegeneration and for rationally 
testing next-generation oligomer inhibitors. While the fluorescence response of extrinsic fluorescent 
probes such as Thioflavin-T have become workhorse tools for characterizing large AE aggregates in 
solution, it is widely accepted that these methods suffer from many important drawbacks, including 
an insensitivity to oligomeric species. Here, we integrate several biophysics techniques to gain new 
insight into oligomer formation at the single-molecule level. We showcase single-molecule stepwise 
photobleaching of fluorescent dye molecules as a powerful method to bypass many of the traditional 
limitations, and provide a step-by-step guide to implementing the technique in vitro. By collecting 
fluorescence emission from single AE(1-42) peptides labelled at the N-terminal position with HiLyte 
Fluor 555 via wide-field total internal reflection fluorescence (TIRF) imaging, we demonstrate how to 
characterize the number of peptides per single immobile oligomer and reveal heterogeneity within 
sample populations. Importantly, fluorescence emerging from AE oligomers is diffraction-limited and 
cannot be easily investigated using conventional optical microscopy tools[SQ1].  To assay oligomer 
activity, we also demonstrate the implementation of another biophysical method involving the 
ratiometric imaging of Fura-2-AM loaded cells which quantifies the rate of oligomer-induced 
dysregulation of intracellular Ca2+ homeostasis. We anticipate that the integrated single-molecule 
biophysics approaches highlighted here will develop further and in principle may be extended to the 
investigation of other protein aggregation systems under controlled experimental conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
The amyloid-E peptide (AE) is derived via the proteolytic cleavage of the transmembrane amyloid 
precursor protein (APP) and ranges in length from 39 to 43 amino acids[1]. The longer peptides 
composed of 40- and 42- amino acids, so called AE(1-40) and AE(1-42), respectively, are observed in 
ďŽƚŚ ŚĞĂůƚŚǇ ĂŶĚ ůǌŚĞŝŵĞƌ ?Ɛ ĚŝƐĞĂƐĞ  ? ? ďƌĂŝŶ ƚŝƐƐƵĞ ?with extracellular concentrations of AE 
estimated to be in the picomolar to low nanomolar range[2]. Intriguingly, this is several orders of 
magnitude lower than concentrations used in most studies designed to evaluate their structure, 
interactions and neurotoxicity. Mass-spectrometry based methods have, for example, recently 
estimated the concentration of AE(1-42) in human cerebrospinal fluid to be 1.5 nM[3], and the rate of 
AE production is approximated to be 2-4 peptides per second per neuron[4]. While concentrations of 
AE(1-42) an order of magnitude lower (0.1 nM  ? 0.3 nM) have also been suggested to facilitate long-
term potentiation, and recent evidence points towards a role for the AE(1-42) monomer as an 
antimicrobial peptide[5, 6], it is well established that AE(1-42) has a tendency to convert from a native 
and soluble form to an insoluble aggregated form, and that this conversion heavily influences cell 
viability[7, 8]. In the context of AD, AE(1-42) aggregation and neurotoxicity is widely considered to be a 
major hallmark.  
AE(1-40) represents the most abundant form of the peptide, comprising ~90% of the AE pool, while 
AE(1-42), comprises only 10 % and contains two additional hydrophobic residues (isoleucine and 
alanine) at the C-terminus[9]. NMR-guided simulations of both structures suggest that this hydrophobic 
region is rigid due to the presence of E-hairpins formed by residues 31-34 and 38-41, and that this in 
turn may be partly responsible for a greater propensity of AE(1-42) to aggregate[8, 10]. AE self-assembly 
is highly dependent on environmental factors (including pH, temperature and ionic strength) and a 
variety of morphologies are known to co-exist along the aggregation pathway. These structures range 
from low-mass oligomers to the high-mass fibrils and plaques characteristic of an advanced AD 
brain[11-15] (Figure 1), and although early research pointed towards fibrils and plaques as being the 
harmful species, focus has now shifted towards pre-fibrillar oligomers as being the predominant 
neurotoxins[16].  
Oligomers are generally classified as AE-derived diffusible ligands (ADDLs) ranging from 12kDa trimers 
to 108 kDa 24-mers[17, 18], spherical or annular oligomers of diameter 3-30 nm[19], and larger curvilinear 
protofibrils 4-11 nm in diameter and A? ? ? ?ŶŵŝŶůĞŶŐƚŚ[20, 21] (Figure 1). While much has yet to be 
learned about the dynamic time-dependent assembly of the oligomeric species, they are believed to 
act as nucleation seeds for the oligomerization of AEmonomers, and generally precede the formation 
of high-mass E-sheet rich fibrils and plaques. Although AE(1-42) has served as a test-bed for probing 
peptide aggregation in vitro[22-24], and mounting evidence now implicates AE oligomers in synapse 
impairment, reduced cognition and neuronal death[25, 26], the mechanisms through which single AE(1-
42) peptides self-assemble and how the resulting structures confer neurotoxicity is still a hot topic of 
debate. One prevailing hypothesis suggests that AE(1-42) oligomers promote toxicity through a direct 
membrane disruption mechanism[27], with recent work implicating contact-induced dynamic 
ƉĞƌƚƵƌďĂƚŝŽŶ ŽĨ ƚŚĞ ĐĞůů ?Ɛ ŵĞĐŚĂŶŝĐĂů ƉƌŽƉĞƌƚŝĞƐ ĂƐ ďĞŝŶŐ ĂŶ ƵŶĚĞƌůǇŝŶŐ physical factor[28]. Recent 
single-molecule approaches also indicate that small soluble AE(1-42) oligomers induce heightened 
levels of membrane permeabilization relative to larger species, though the magnitude of the 
disruption process varies between oligomeric forms[29]. Despite the lack of clarity on the mechanisms 
of toxicity, it is now abundantly clear that fibrillar and plaque-like aggregates correlate poorly with AD 
symptoms and that oligomers are orders of magnitude more harmful to living cells[30-32]. 
Understanding the mechanisms of AE oligomer assembly and neurotoxicity thus demands the 
development of experimental approaches capable of characterizing their stoichiometry, time-
dependent heterogeneity and interactions under a wide range of environmental conditions, and, at 
physiological concentrations of the molecular reagents. 
 
Figure 1. Schematic illustration of the time-dependent AE self-assembly process. AE monomers (blue) 
self-assemble into a series of low-mass oligomers (yellow), including amyloid-derived diffusible ligands 
(ADDLs), spherical oligomers and protofibrils, and high-mass fibrils (green) and plaques (red). While the 
precise time scales and morphological structures of AE aggregates are time-, concentration- and 
environment-sensitive, mounting evidence points to the low-mass oligomers as being the predominant 
neurotoxins. Not drawn to scale.  
In recent years a number of structural techniques including cryo-electron microscopy (cryo-EM), 
electron diffraction, X-ray diffraction and solid-state NMR have provided high-resolution insights into 
AE assemblies either prepared in vitro or extracted from human brain tissue. Most of this work has 
involved the investigation of AE fibrils, and have broadly indicated that a complex interplay of bonding 
interactions, together with solvent and co-factor binding, structured cores and local disordered areas 
all contribute to their construction[33, 34]. Notably, recent cryo-EM studies on AE fibrils purified from 
human tissue have demonstrated that they are not only polymorphic but consist of similarly ordered 
protofilaments[35]. While such techniques have undoubtedly provided valuable structural insight, they 
generally either lack the ability to probe dynamic time-dependent changes and/or require non-
physiological concentrations and conditions. In this context, the application of optical techniques 
based on absorption and fluorescence spectroscopy have been the most commonly used for 
aggregate detection and characterization[36-38]. For instance, the fluorescence intensity enhancement 
associated with small extrinsic molecules such as Thioflavin-T (ThT)[36] upon aggregate binding has 
become a workhorse tool for detecting a wide range of E-sheet rich AE aggregates in vitro. However, 
it is also well established that extrinsic probes may compete with aggregation inhibitors, which limits 
their use as screening tools[39] and suffer from a reduced affinity to the aggregated species at low pH 
due to local electrostatic repulsive effects[40]. Moreover, their mechanism of interaction is highly 
dependent on the formation of binding pockets along the aggregated structure, and their mode of 
binding has yet to be fully established[40, 41]. Consequently, extrinsic probes generally suffer from an 
inherent insensitivity to small oligomers that lack the necessary binding sites[42, 43]. In recent years, it 
has thus become abundantly clear that one of the fundamental barriers to progress in the fight against 
AE induced neurodegeneration arises from the intrinsic polymorphism of the oligomers, their time-
dependent heterogeneity and the need to identify and selectively target distinct oligomeric species[44]. 
However, to complicate matters, additional challenges associated with investigating the details of a 
process as complex as AE oligomerization through optical microscopy methods arise from the fact that 
despite visible light enabling time-dependent dynamics to become accessible, a relatively poor spatial 
resolution is achieved compared to X-ray or electron microscopy. The problem here is that diffraction 
effects limit the spatial resolution to approximately the optical wavelength divided by twice the 
magnitude of the numerical aperture of the imaging system. For most setups, the numerical aperture 
is in the range 1.2-1.6, yielding a typical spatial resolution limit of ca. 180 nm for visible light of 500 
nm. Furthermore, most biochemical assays involving extrinsic dyes rely on an average fluorescence 
signal from an assortment of large aggregates, oligomers and monomers, which masks heterogeneity 
within a sample population and fails to report on the presence of transient, intermediate and/or rare 
species. In this regard, single-molecule methods have emerged as a powerful means to characterize 
single oligomeric species, one-at-a-time, to unveil the distribution of species present in solution, 
effectively revealing the type and relative abundance of oligomers that are otherwise hidden by the 
ensemble average. With the development of single-molecule approaches the behaviour of single AE 
oligomers can be probed with new levels of detail, greatly reducing the chance that such important 
information is bypassed[45]. Beyond these motivations, studying AE(1-42) self-assembly at 
physiological concentrations is a major hurdle for most biochemical assays, yet single-molecule 
detection techniques[46] are uniquely placed to overcome this challenge due to the intrinsic 
requirement for picomolar concentrations of fluorophores[47].  
In recent years a number of single-molecule approaches have been employed to characterize oligomer 
size, growth, composition and interactions. For example, fluorescence imaging has been combined 
with near-infrared optical trapping to reveal the growth rate of single AE(1-42) species over the course 
of several hours[48]. Single-molecule Förster resonance energy transfer (smFRET) experiments, which 
quantitatively report on the separation distance between a donor and acceptor fluorophore over the 
range of approximately 1-10 nm, have also been used to reveal a broad distribution of interconverting 
conformations in AE(1-40) and AE(1-42) monomers with fluctuation timescales of order 35 ns[49]. 
Additional confocal-based FRET-sensing approaches involving N-terminally labelled AE(1-42) and 
synthetic liposomes incorporating TRITC in the lipid bilayer region have provided dynamic and 
temporal insight into oligomer-membrane interactions and when combined with fluorescence 
correlation spectroscopy, the method has enabled detection of extremely low stoichiometry 
populations of oligomers containing <10 AE(1-42) peptides[50]. Another confocal-based strategy that 
has enabled the rapid detection of oligomers composed of two different labelled AE peptides in 
solution utilizes two-colour excitation and the detection of coincidence fluorescence bursts. For 
example, converged blue and red lasers have facilitated identification of Alexa Fluor 488- and Alexa 
Fluor 647-labelled AE(1-40) and AE(1-42) monomers as they pass through the confocal volume, while 
also enabling detection of mixed-label species[51, 52]. In many such confocal-geometry based 
experiments, the observation time window is limited to only the few milliseconds the labelled 
aggregate takes to diffuse through a confocal volume, and given a heterogeneous distribution of 
oligomers with different diffusive properties, the fraction of molecules that is actually analysed 
depends strongly on the measurement time, the excitation intensity and the size of the reservoir 
associated with each freely diffusing species.  
Recent additions to the array of single particle techniques applicable to the study of amyloidogenic 
assembly includes interferometric scattering mass spectrometry (iSCAMS), whereby the scattering 
intensity obtained from single biomolecules in solution is used to quantify mass. In this scenario, the 
scattering signal is proportional to the peptide mass and has been used to identify the binding of low-
order oligomers composed of relatively large (66.5 kDa) molecular weight proteins[53]. However, in the 
context of much lower molecular weight species implicated in neurodegeneration, the technique is 
currently unable to determine the stoichiometry of small nucleating oligomers, evaluate individual 
assembly steps and has the intrinsic requirement for low-scattering in vitro conditions. 
Of all single-molecule based techniques, the stepwise-photobleaching method, based on the long-
term imaging of tracked biomolecules, has been the most widely implemented for assessing 
biomolecular size distributions[47, 54-57] (Figure 2). Photobleaching takes place when the excited 
fluorophore permanently loses its ability to fluoresce due to photon-induced chemical damage and 
covalent modification. While the average number of excitation and emission cycles that take place 
prior to photobleaching is dependent on the fluorophore structure and local environment, and the 
rate of photobleaching can be altered by modification of the excitation intensity, the complete loss of 
fluorescence is exploited to unambiguously determine the number of peptides-per-oligomer. Here, 
each AE peptide carries a single fluorescent molecule, and upon excitation, each label within an 
immobilized oligomer photobleaches, providing a stepwise fluorescence trajectory in which each step 
in a sampling time window corresponds to the bleaching of an integer number of fluorophores, 
typically with several single molecule steps in the case of low stoichiometry complexes and especially 
towards the end of a photobleach time course[58]. By counting the number of photobleaching steps, 
in a probabilistic manner, it is therefore possible to identify the number of peptides-per-oligomer 
(Figure 2). The method involves the direct counting of all single molecule photobleaching steps and is 
typically limited to the detection of 10-mers, beyond which the trajectories become exponential-like 
and require other analytical approaches such as Fourier spectral analysis[59], but nevertheless the 
direct single step counting method has been employed by a number of groups in the field. For 
example, the stepwise photobleaching of AE(1-40) peptides labelled with fluorescent dyes at the N-
terminus has been used to characterize the distribution of oligomers on supported lipid bilayers[60], 
naked glass coverslips[54] and polyethylene glycol-coated substrates[47]. These systems are of course 
highly artificial, each have their own practical limitations with regards to substrate compatibility, and 
they may influence AE-surface binding, meaning caution should be taken with the interpretation of 
data in the context of a physiological environment. However, such in vitro systems offer an excellent 
opportunity to explore the effect of environmental conditions on AE oligomerization within in a 
controllable, tuneable and water-soluble environment in the absence of the many extraneous 
biochemical processes found in vivo. In the latter case, picomolar concentrations of FAM-labelled 
AE(1-40) monomers were shown to oligomerize into a series of dimers, trimers, tetramers and 
pentamers in the presence of acidic conditions and zinc coordination. The technique has even 
extended to the detection of Alexa Fluor 647-labelled cys-AE(1-42) in human cerebrospinal fluid[61]. In 
all cases, the total fluorescence intensity obtained for each oligomer also scales with the number of 
peptides, enabling a second optical fingerprint to be obtained from the same experiment.  Clearly this 
method holds substantial promise for the quantification of AE oligomer size distributions and has 
already been demonstrated to operate over a wide variety of experimental conditions.  
 
 
 Figure 2. Overview of the single-molecule stepwise photobleaching method to evaluate oligomer 
stoichiometry. (a) Wide-field single-molecule imaging techniques such as total internal reflection 
fluorescence (TIRF) microscopy utilize a high numerical aperture objective lens to totally internally reflect 
excitation light at the boundary between a glass coverslip and sample, forming an evanescent field which 
decays exponentially into the sample. Typical penetration depths, ', are ca. 100-200 nm. In this case, only 
immobilized oligomers, composed of labelled peptides are stimulated to emit fluorescence, minimizing 
background fluorescence from the ensemble solution. (b) A representative wide-field image of immobilized 
and spatially separated oligomers composed of AE(1-42) peptides labelled at the N-terminus with the 
fluorescent molecule HiLyte Fluor 555 (Oex = 532 nm). (c) A representative false-colour point-spread function 
obtained from a single immobilized oligomer as a function of time displays a stepwise decrease in integrated 
signal intensity, enabling the number of monomeric subunits to be counted. In the fluorescence trajectory 
shown in (d), the presence of four discrete stepwise photobleaching events corresponds to the identification 
of a tetramer. 
In this work, we describe the implementation of a wide-field, objective-based, total internal reflection 
fluorescence microscopy imaging method to access the stepwise-photobleaching trajectories 
obtained from single surface-immobilized oligomers composed of AE(1-42) peptides labelled at the N-
terminal position with HiLyte Fluor 555 (AE555), a member of the cyanine family of fluorescent 
compounds. Given that soluble oligomers formed at different stages of the aggregation process have 
been shown to induce permeabilization of the lipid bilayer, we also describe a ratiometric fluorescence 
assay that provides a quantifiable real-time metric of intracellular Ca2+ levels in response to the 
injection of pre-formed and robustly characterized AE555 oligomer populations.  
In the sections that follow, we describe a series of procedures that enable AE555 oligomer 
stoichiometries to be measured via the quantized stepwise photobleaching method, which can then 
be correlated against orthogonal data from a ratiometric assay for quantifying AE555 activity using a 
live-cell approach, such that the integration of these two approaches provides far more insight than 
using the approaches in isolation. We also describe the process of data acquisition and analysis, 
provide representative data sets, and identify troubleshooting hints.  
2. Methods 
2.1  AE555 Preparation and handling 
Lyophilized $E555 peptides were purchased from Cambridge Bioscience (UK) (part number ANA60480-
01). N-terminal attachment of the AE peptides to HiLyte Fluor 555 (Figure 3a, b) was performed by 
the manufacturer and purification was characterized using mass spectroscopy and high-performance 
liquid chromatography. HiLyte Fluor 555 is a derivative of the widely used Cy3 dye which has 
absorption and fluorescence emission peaks at 551 nm and 567 nm, respectively (Figure 3c). Despite 
exhibiting a shorter Stokes shift relative to Cy3, the molecule contains a long chain linking both 
aromatic groups which minimizes flexibility and reduces the probability of photoblinking. To prepare 
AE555 for analysis, it is first important to monomerize the lyophilized stock. This can be achieved by 
dissolving the lyophilized peptides directly from the manufacturer in hexafluoroisopropanol (HFIP) 
(Sigma Aldrich, part number 105228) to a concentration of 0.2 gL-1. Once dissolved, the solution can 
be aliquoted into 10 PL volumes in Protein LoBind tubes (Eppendorf, Part Number 0030108116) in 
accordance with well-established procedures used by us and many others[24, 62-65]. Aliquots should then 
be desiccated under vacuum for 5-6 hours at room temperature to remove HFIP, and stored at -20oC 
prior to use.  
SDS-PAGE can be employed to assess whether the procedure is successful at producing mostly 
monomeric species. In this regard, we used a self-poured 15 % acrylamide Tris-glycine protein gel (10 
well, 30 PL per well). Here, 2 Pg of aliquoted AE555 was suspended in 4 PL of anhydrous dimethyl 
sulfoxide (DMSO) (Sigma Aldrich, part number 276855) and subsequently diluted in 1 x SDS loading 
buffer (50 mM Tris, pH 6.8, 2% (w/v) SDS, 0.05% (w/v) bromophenol blue, 10% (v/v) glycerol and 5% 
 ?ǀ ?ǀ ?ɴ- mercaptoethanol). Gels were then run at 220 V for 75 min. A pre-stained molecular weight 
ŵĂƌŬĞƌ  ?WƌĞĐŝƐŝŽŶ WůƵƐ WƌŽƚĞŝŶ ? ƵĂůXtra Prestained Protein Standards, Bio-Rad) was used to 
determine the end-point of the electrophoresis and fluorescence images of the gel were captured 
using a Gel-Doc system (Bio-Rad). Since AE(1-42) is known to produce SDS-resistant aggregates[66], we 
used the gel to visualize the abundance of species present in solution. Immediately after preparation, 
only a single band consistent with the presence of monomeric AE555 at ~5.4 kDa was observed (Figure 
3d). 
 Figure 3. Schematic of the AE555 peptide used for single-molecule photobleaching studies. (a) AE1-42) (blue, 
PDB ID = 1IYT)[67] is labelled at the N-terminus with HiLyte Fluor 555. The accessible volume (AV) of the dye is 
illustrated by the semi-transparent red surface and was calculated using a freely available structural modelling 
algorithm[68] in which a linker length of 13 Å was used and the dye was modelled as a single ellipsoid with radii 
R1 = 7.1 Å, R2 = 11.1 Å and R3 = 4.9 Å as estimated with ChemDraw after energy optimization with MMFF94 
minimization. (b) The sequence of AE555. Hydrophobic residues at the C-terminus are highlighted in yellow. (c) 
Normalized absorption (blue solid line) and fluorescence emission (red dashed line) spectra of AE555 in 50 mM 
Tris buffer (pH 8). (d) Fluorescence image of denaturing SDS-PAGE gel of AE555 immediately after the preparation 
process indicates a lack of pre-formed high-mass aggregates.  
2.2  AE555 oligomer preparation 
A number of well-established procedures may be followed to produce low-mass oligomers in vitro[24, 
52, 69-71]. However, for the purposes of proof-of-principle of this method, we were interested in the 
preparation of small globular oligomers. These can be prepared by suspending freshly prepared AE555 
monomers in 1-5 PL of DMSO and thereafter immediately diluting in aggregation buffer to a final AE 
concentration of 1  ? 10 pM. We use 50 mM Tris buffer (pH 8) containing 4 % (v/v) HFIP and < 1 % 
(v/v) DMSO as the aggregation conditions to stimulate oligomerization. While high concentrations of 
HFIP have been popular agents for the monomerization of peptides, low concentrations in the range 
1-4 % (v/v) are known to rapidly promote the formation of AE oligomers[24, 70] via a mechanism 
involving the formation of HFIP micro-droplets in solution that act as interfaces to promote 
aggregation. Although it is not yet clear if these oligomers represent a biologically relevant 
ŵŽƌƉŚŽůŽŐǇŝŶƚŚĞĐŽŶƚĞǆƚŽĨůǌŚĞŝŵĞƌ ?ƐĚŝƐĞĂƐĞƉĂƚŚŽůŽŐǇ ?ƚŚĞĂĐĐĞůĞƌĂƚŝŽŶŽĨE aggregation has 
already been observed at the interface of biomimetic membranes[72]. Additionally, highly fluorinated 
compounds, similar to HFIP, have been shown to promote the formation of AE structures that may be 
related to the appearance of cognitive defects[73]. The timescale of 1-2 % (v/v) HFIP-induced 
aggregation of AE(1-40) has also been shown to rapidly reduce from weeks to minutes[71], motivating 
us to examine AE(1-42) oligomerization under similar working conditions.  
2.3  Microscope flow-cell fabrication and immobilization of AE555 oligomers 
Single-molecule stepwise photobleaching trajectories were obtained from AE555 oligomers 
immobilized onto the surface of a pre-cleaned glass coverslip (22 x 50 mm, No. 1.5 thickness, Scientific 
Laboratory Supplies Ltd, part number MIC3246), which formed part of a ~1 cm wide microscope flow-
cell. A schematic illustration of the flow-cell is shown in Figure 4. The text that follows provides a step-
by-step guide to fabricating flow-cells and performing oligomer immobilization.  
To begin the process of preparing a flow-cell, first drill two holes (I= 1 mm) in 25 x 75 x 1 mm glass 
microscope slides (Polysciences Inc., part number 22245) for the purposes of sample injection into the 
flow-cell via pipette tip as schematically shown in Figure 4a. It is worth noting that flow-cells were 
typically prepared in batches of five. Small diamond core drill bits (Eternal Tools, UK, part number 
SDCD1100) were used to drill 1 inlet and 1 outlet hole per slide. Prior to flow-cell fabrication, each 
pre-drilled microscope slide and glass coverslip must then be thoroughly cleaned as per steps 1-3 
below:  
1) To begin the cleaning process sonicate each of the pre-drilled microscope slides and coverslips in 
the following solutions sequentially: 2 % Hellmanex III, 98 % ultra-pure water solution (15 min), 
ultra-pure water (5 min), acetone (15 min), ultra-pure water (5 min), 1 M potassium hydroxide (15 
min), ultra-pure water (5 min), methanol (15 min), ultra-pure water (5 min), 1 M potassium 
hydroxide (15 min), ultra-pure water (5 min). After each solvent step, rinse the slides and 
coverslips thoroughly with ultra-pure water.  
2) Slides and coverslips can be washed one day and refreshed the next. To refresh, sonicate each slide 
and coverslip sequentially in ultra-pure water (5 min), 1 M potassium hydroxide (15 min) and ultra-
pure water (5 min).  After the wash step involving potassium hydroxide, the slides and coverslips 
must be rinsed thoroughly with ultra-pure water. Slides and coverslips are stored for up to one 
week in ultra-pure water after cleaning if refreshed daily.   
3) When ready to be used, gently dry each slide and coverslip using filtered nitrogen gas and remove 
any residual water droplets.  
Next, fabricate flow-cells by applying double-sided tape to the pre-cleaned microscope slide as 
demonstrated in Figure 4a in order to construct the walls of the chamber. Care should be taken to 
ensure a channel thickness of ~1 cm. Apply a pre-cleaned glass coverslip on top to form the ceiling of 
the chamber and gently push it against the tape using a pipette tip to complete fabrication. Remove 
residual tape carefully with a razor blade and seal the edges of the chamber using epoxy adhesive 
(Araldite, part number ARA-400012). 
 Figure 4. A schematic illustration of the flow-cell manufacturing process. (a) Double sided tape is placed on a 
pre-cleaned glass microscope slide containing 1 inlet and 1 outlet hole for sample injection. A pre-cleaned glass 
microscope coverslip is added directly on top of the double-sided tape to form a chamber. (b) After coating the 
interior of the chamber with poly-l-lysine and the injection of pre-formed AE555 complexes, the fluidic chamber 
is placed coverslip down onto an oil immersion objective lens housed in an inverted microscope to enable 
monitoring of surface immobilized oligomers.  
Note that it is possible to re-use glass microscope slides from flow-cells after use. Removal of used 
coverslips, double-sided tape and epoxy may be achieved by submerging the used chambers in 
acetone for 1-2 h, then carefully removing the coverslip, epoxy and tape from the slide using a razor 
blade. After removal, slides should be sequentially scrubbed with optical tissue soaked in acetone and 
methanol until visibly clean, before being subjected to the cleaning procedure outlined in steps 1-3. 
Depending on the usage, the slide cleaning procedure for re-used slides may require an additional 
etching step prior to steps 1-3. In this case, pre-scrubbed slides and coverslips can be transferred to a 
fume hood and submerged in a 50:50 mix of hydrogen peroxide and hydrochloric acid for 1-2 h. Slides 
should be left for no longer than 2 h. Etched slides must then be thoroughly rinsed with ultra-pure 
water prior to the cleaning procedure. 
In order to immobilize pre-formed AE555 oligomers or freshly prepared AE555 peptides, first coat the 
flow-cell with 60-100 PL of 0.1 % poly-l-lysine (MW = 150-300 kDa, Sigma Aldrich, part number P8920).  
Flush the solution into the flow-cell using a pipette tip injected into an inlet hole and incubate the 
chamber for 15 min at room temperature. Attachment of biological molecules to glass surfaces has 
frequently been accomplished via electrostatic interactions with poly-L-Lysine[74, 75] and in this case, 
we utilize the approach to bypass the need for any additional functionalization of the peptide. Here, 
the negative surface charge associated with AE(1-42) enables the positively charged poly-l-lysine 
polymers to become effective for non-specific immobilization. After 15 min, rinse each flow-cell with 
3 x 100 PL of buffer to remove any unbound polymers. Following the wash step, flush 60-100 PL of 
freshly prepared AE555 or pre-formed AE555 oligomers at 1-10 pM onto the poly-l-lysine coated surface. 
It is important to note that the AE555 solutions must not be diluted prior to being flushed into the 
chamber, as serial dilutions may alter the final aggregated state. The flow-cell is now ready to be 
imaged by total internal reflection fluorescence (TIRF) microscopy.  
2.4 Microscope Setup: Objective-based total internal reflection fluorescence microscopy 
For single molecule photobleaching experiments, we utilized a custom-built objective-based TIRF 
geometry for fluorophore excitation. Figure 5 shows a schematic illustration of the microscopy optics.  
All lenses, translation stages and mirrors (part number BB1-E02) were purchased from Thorlabs Inc., 
USA unless otherwise specified. All optical components had anti-reflection coatings for optical 
wavelengths in the range 350 - 700nm.   
In our setup, a TEM00 continuous wave 532 nm excitation line (Coherent Ltd., UK, OBIS 532 nm LS 50 
mW part number 1261780) was circularised with a quarter waveplate (Thorlabs, AQWP05M-580) and 
expanded with a 3× telescope (comprised of expansion lens: f=100 mm planoconvex LA1509-A-ML 
and steering lens: f=300 mm achromatic doublet AC254-300-A-ML), with the latter mounted on an x-
y translation stage (part number LX20/M). We note that one is able to select from a wide variety of 
solid-state, diode, or gas lasers to optimally match the illumination wavelength to the absorption 
spectra of the fluorescent probe, and in principle the maximum excitation wavelength is 550 nm. In 
this work we used an optically pumped semiconductor laser at 532 nm to excite HiLyte Fluor 555 at 
55 % of maximum absorption, though 543 nm or 546 nm lines could offer further optimization. The 
expanded beam was focused using a third biconvex lens (part number LB1779-A-ML) and directed by 
periscope (part number RS99) onto the back aperture of an oil-immersion objective lens (Nikon CFI 
Apo TIRF 100x NA 1.49, part number MRD01991) housed within an inverted fluorescence microscope 
(Nikon Eclipse Ti) such that the size, location and illumination scheme could be easily altered if needed, 
for example with a neutral density filter wheel (part number FW1AND).  The laser was focused onto 
the back aperture of the objective lens such that a collimated beam incided onto the internal coverslip 
face of the flowcell at an angle beyond the glass-water critical angle, thus sustaining total internal 
reflection.  The coverslip was optically coupled to the objective lens by a thin layer of fluorescence-
free objective immersion oil (Olympus, part number IMMOIL-F30CC). The emission was then 
separated from the laser line with a filter cube (Chroma Technology Corp., part number 59907-ET-
532/640nm Laser Dual Band Set, including excitation filter, dichroic beamsplitter and emission filter). 
After the filter cube, mirror, and f=200 mm tube lens within the microscope body, the detection path 
exited the microscope frame at the lower side port. Another 3× telescope (comprised of achromatic 
doublet lenses AC254-50-A and AC254-150-A with f=50 mm and f=150 mm, respectively) was then 
used to magnify the image.  In turn this magnified image was relayed onto an EMCCD camera (iXon 
Ultra 897, Andor Technology Ltd.). The particular implementation used a 1:1 commercial DV2 relay 
telescope from Photometrics Inc, albeit set to bypass the colour splitting function.  This image 
magnification corresponds to an object-plane pixel size of 50 nm on the camera, or roughly 15 pixels 
per diffraction limited spot. 
 Figure 5. A schematic illustration of the objective-based TIRF microscope used for stepwise photobleaching 
experiments. The excitation source and optics are shown. Detailed descriptions of all optical components are 
found in the main text. The dotted green line represents the excitation path in epi-illumination mode. The figure 
is for schematic illustration only and is not drawn to scale.  
In order to build the objective-based TIRF microscope, the following procedure should be adopted. 
First, the excitation laser needs to be aligned to the centre of the microscope field of view. Steps 1-5 
below provide a practical guide to achieving this. Refer to safety considerations at the end of this 
procedure before attempting any alignment process. 
1) Before firing the laser, fix the laser head facing away from and offset from the microscope 
input port (Figure 5).  Set up the periscope in front of the port, with the upper mirror directed 
into the port and the lower mirror facing away. Set up the steering mirrors and neutral density 
filter wheel in line with the laser head, such that the mirrors each turn the beam through an 
approximate right angle and the output beamline points towards the lower periscope mirror. 
Unscrew the objective. At an eye safe laser power (< 1mW at source), adjust the mirrors and 
ƉĞƌŝƐĐŽƉĞ ƚŽ  ‘ǁĂůŬ ƚŚĞ ďĞĂŵ ? ďǇ ĐŽƵŶƚĞƌ-adjusting the mirrors until the beam emerges 
centrally from the objective turret. Disable the laser and fix the mirrors in place.  
 
2) Assemble the focusing lens onto an x-y adjustable mount and place at a focal length (f3 = 300 
mm) from the back aperture of the objective lens along the optical axis.  Replace the objective 
and, with the beam visible, adjust the focusing lens until the beam again emerges centrally 
and collimated from the objective, such that the beam projection is symmetrical and minimal 
in size.  Turn the laser off. 
 
3) Mount the steering lens in an x-y adjustable mount on the linear translation stage.  Set this at 
a distance upstream from the focusing lens, equal to the focal length of that focusing lens (f3 
= 300 mm). Ensure that the curved face of the steering lens is facing toward the focusing lens. 
Turn the laser on and adjust this mount until the beam is centred both on the lens and through 
the objective; the beam centre may appear very diffuse, in which case adjust for maximum 
power through the objective.  Failing this, turn the laser off and unscrew the focusing lens 
making sure to retain its position, and retry adjusting the steering lens with the laser on.  Then 
turn the laser off and replace the focusing lens. 
 
4) Starting from the steering lens position, place the expansion lens further towards the laser 
source at a distance equal to the sum of the focal lengths of the expansion lens (f1 = 100 mm) 
and of the steering lens (f2 = 300 mm; i.e. f1 + f2 = 400 mm) (Figure 6a).  Point the curved face 
of the expansion lens toward the source to minimize aberrations in the beam.  As before, turn 
the laser on and adjust this lens to centre and collimate the beam output from the objective. 
 
The ratio of the two focal lengths (f2/f1 = 3) determines the magnification of the beam, in this 
case to expand the beam from an initial diameter (at 1/e2  intensity) of 1.3 mm at the 
expansion lens, to a diameter of 3.9 mm at the focusing lens.  Together with the ratio of the 
second telescope formed by the focusing lens and objective (fobj/f3 = 1/150) (Figure 6a) this 
gives the expected size of the illuminated region in the field of view (d = 3.9 mm / 150 = 26 
µm). 
 
5) Note the Vernier scale position of the lateral micrometer on the steering lens and move this 
to the nearest reproducible mark.  Record this position as xo.  Readjust the periscope mirrors 
to compensate the laser movement. The microscope is now in a crudely calibrated narrowfield 
fluorescence configuration and the vertically-propagating laser can be used as a reference for 
the central axis of the objective. 
The next goal is to align the detection optics (steps 6-9).   
6) Project a diffuse light source (such as a brightfield lamp and condenser) through the objective 
and tube lens to produce a broad beam of light from the side port.   Place and align the steering 
mirrors to transmit this beam onto the camera via the relay telescope, leaving enough room 
near the port for the magnifying telescope lenses (> f4 + f5 = 200 mm).  The second relay lens 
must be set a focal length (f5) away from the entrance of the relay telescope (Figure 6b). 
  
7) Place a droplet of immersion oil on the top of the objective lens.  Obtain a pinhole whose size 
is roughly double the expected laser size (e.g. d = 50 µm, part number P50D).  Secure the 
pinhole to a microscope slide with which its position can be controlled using the microscope 
stage.  Adjust the pinhole until the laser emerges with maximum transmitted power.  Disable 
the laser but do not move the pinhole. 
 
8) Activate the camera software of choice.  Under brightfield illumination, finely adjust the 
detection steering mirrors, walking the image until the pinhole is centred and focused within 
ƚŚĞĐĂŵĞƌĂ ?ƐĨŝĞůĚŽĨǀŝĞǁ ? 
 
9) Place the magnification lenses in one after the other, separated by f4 + f5 = 200 mm (Figure 
6b), adjusting each until the scene reappears and the pinhole is recentred, this time with the 
correct magnification.  Alternatively, use field stops at the positions where the magnification 
lenses will be placed to ensure these are centred on the field of view. Both excitation and 
detection paths are now crudely aligned with one another. 
Next, locate fluorescence emission from bright microspheres arising from the illumination spot at the 
centre of the field of view and perform final fine-tuned alignments of the excitation and detection 
optics as documented in steps 10-17. For photobleaching experiments only single-colour illumination 
and detection is required. 
10) Prepare a dilute (~0.002 %) solution of red fluorescent microspheres of diameter 0.2 Pm 
(Thermo Fisher Scientific, Part Number F8810) in 50 mM Tris, 100 mM NaCl buffer (pH 8.0). 
Add the solution to a pre-constructed flow chamber and incubate for 10-15 minutes at room 
temperature. After incubation, flush the chamber with buffer to remove any microspheres 
unattached to the glass coverslip.  
 
11) Place a droplet of immersion oil on the top of the objective lens and mount the flow chamber 
containing the microspheres on top. 
 
12) If the laser beam / fluorescent beads do not appear in the field of view, set the lateral 
micrometer to the calibrated narrowfield position xo. Then, find the position of the laser on 
the field of view by moving the lower periscope mirror. 
 
13) Complete the narrowfield (zero angle of incidence) alignment by redirecting the laser i) 
through the centre of the objective lens (i.e. in the projection) using the lower periscope 
mirror and ii) back onto the camera field of view with the upper periscope mirror.  Iterate i) 
and ii) until the laser is centred in both planes. 
 
14) Image the fluorescent microspheres on the camera and focus being careful to use a low 
electron multiplication gain. An integration time of 50-100 ms will suffice for imaging 
purposes.   
 
15) &ŽƌĂƌŽďƵƐƚĂůŝŐŶŵĞŶƚ ŝŶǁŚŝĐŚƚŚĞďĞĂŵ ?ƐĂŶŐůĞŽĨ ŝŶĐŝĚĞŶĐĞĐĂŶďĞǀĂƌŝĞĚĐŽŶƚŝŶƵŽƵƐůǇ
ǁŝƚŚŽƵƚƚŚĞďĞĂŵ ‘ǁĂůŬŝŶŐŽĨĨ ?ƚŚĞĨŝĞůĚŽĨǀŝĞǁ ?ƚŚĞĞǆĐŝƚĂƚŝŽŶƐƚĞĞƌŝŶŐůĞŶƐŵƵƐƚƐŝƚĂƚƚŚĞ
correct distance from the focusing lens.  Achieve this condition by dithering the lateral 
micrometer whilst smoothly varying the longitudinal position of the steering lens, until the 
dithering can no longer be seen on the camera as a change in beam position but only in angle.  
Check this is correct by moving the micrometer to its extremes; the projection of the beam on 
the sample should become increasingly elliptical as the angle of incidence increases, but its 
centre should not move.  Walk the periscope mirrors to recentre the beam in the field of view. 
 
16) Translate the micrometer until the beam surpasses the glass-water critical angle and the 
excitation becomes restricted to the interface.  Refocus to image this layer; only microspheres 
sufficiently close enough to the glass coverslip will yield signal.  The surface signal reaches a 
maximum relative to the background, before quickly clipping/disappearing as the beam is 
translated off the rear of the objective lens.  This condition of maximum signal to background 
ratio results from the standing-wave amplification and signifies the optimal TIRF that can be 
achieved using the setup. 
 
17) Most commercial excitation lasers are linearly polarised, as in this case. The polarisation can 
be checked by rotating a linear polarising film (such as LPVISE2X2) in the beam at low power 
(~1mW, making use of the neutral density filters as necessary) and detecting extinction along 
a particular axis.  Insert the Ȝ/4 waveplate in a rotating mount (RSP1D/M) into the excitation 
path near the laser head. To circularise the output beam, the waveplate should be rotated 
such that the input polarisation axis is halfway between the fast and slow axes of the 
waveplate. If fluorophores near the surface have a fixed or preferred orientation, particularly 
along the direction of beam inclination, the input polarisation may have a modest effect on 
the output signal. If necessary, adjust the quarter waveplate to minimise signal anisotropy. 
 
 
Figure 6. Ray optics diagrams of the objective-based TIRF microscopy setup. Ray diagram and adjacent optical 
elements in the (a) excitation and (b) detection paths are shown. Focal lengths (red text) and magnifications 
(blue text) associated with each component are also shown.  
2.4.1 Angular Calibration 
Once robust alignment is established, the lateral position of the steering lens can be used to build a 
look up table for the beam angle at the front aperture and the corresponding penetration depth. Then, 
any beam angle in the experimentally accessible range can be dialled, even during an experiment and 
without changing the sample.  Our approach requires a prism with refractive index matched to the 
objective immersion medium.  For oil immersion objectives, this is simple to construct by sandwiching 
5-10 pre-cleaned microscope slides together to form a slide stack, with copious amounts of immersion 
oil on each slide to exclude air gaps. Compress the slide stack and remove excess oil from the sides.  
Measure the height of the stack to < 0.1 mm precision with callipers; this should lie in the range 6-12 
mm. Cut a 25 x 75 mm piece of high quality graph paper with precise and fine (e.g. 1 mm) graduations, 
soaking it in immersion oil.  Secure it on top of the stack with an extra slide.  Finally, finish the slide 
stack by sealing the sides with electrical insulation tape. A schematic illustration of the slide stack is 
shown in Figure 7. 
 
 Figure 7.  Schematic of the slide stack procedure to calibrate the angle of the beam by measuring its projected 
displacement as a function of steering lens position. 
Move the steering lens micrometer to the narrowfield position (xo= 3.50mm in this case) and ensure 
the laser is vertically aligned along the axis of the objective. Attach a coverslip to the underside of the 
stack (away from the graph paper) using a drop of oil.  Then apply oil to the microscope objective and 
place the stack on the microscope stage, graph paper upwards. Activate the laser, which should 
project a spot on the paper along the axis of the objective.  Move the stage towards one end of the 
slide, such that a division of the graph paper intersects the centre of the laser spot. Focus on the 
internal surface of the coverslip as usual.  Then, without moving the stage, shift the steering lens 
micrometer in fixed steps and record the displacement of the laser spot, d, as a function of micrometer 
position x. The uncertainty in displacement can be estimated as the semimajor axis of the spot.  
 
Figure 8.  Exemplar data for beam angle calibration measurements. (a) Beam displacement on a slide stack as 
a function of the lateral position of the steering lens (red) and the corresponding angle of the beam emerging 
from the objective front aperture (blue) fitted with cubic function to model slight positive spherical aberration 
(blue dotted line). Note the narrowfield conditions (Ʌǡ = 0) is aligned after the micrometer offset is specified 
at xoൌ3.50mm.  (b) Detail of the angle-micrometer curve (blue) with local linear least squares fit annotated with 
the theoretical glass-water critical angle, ߠ஼ ൎ  ? ? ?,  (dotted black line), the maximum shift admitted by the 
objective back aperture, ߠሺݔ௠௔௫ሻ ൎ  ? ? ?(dashed black line), and the marginal ray at the front aperture, ߠே஺ ൌܽݏ݅݊ሺܰܣȀ݊௢௜௟ሻ  ൎ  ? ? ?(solid black line). Also shown is the theoretical penetration depth, d, (red) across the 
accessible range of supercritical angles. The centre of the projected spot was determined on the linear slide 
scale and its error given by half the length of the projected spot. 
 
At high displacements the beam projection becomes increasingly elongated and eventually the beam 
walks off the back aperture.  Since we use steering and focusing lenses of the same focal length, this 
limit is expected to occur when the steering lens micrometer is shifted by half the objective back 
aperture, such thatݔ௠௔௫ ൎ ݔ௢ ൅ ܰܣ  ? ݂݋ܾ,݆ (in our case 6.48 mm = 3.50 mm +  1.49 x 2 mm). This 
expectation is close to what we observed as shown in Figure 8. 
The angle Ʌat which the beam emerges is related to the displacement d by the simple geometric 
relation ߠ ൌ ܽݐܽ݊ሺ݀Ȁ݄ሻ where h is the stack thickness. For sub-critical angles ߠ ൑  ߠ஼, the beam is 
refracted again at the glass-ƐĂŵƉůĞ ŝŶƚĞƌĨĂĐĞ ĂĐĐŽƌĚŝŶŐ ƚŽ ^ŶĞůů ?Ɛ ůĂǁ ?  ,ŽǁĞǀĞƌ ? ĨŽƌ ƐƵƉĞƌ-critical 
angles ߠ ൐  ߠ஼,  only the evanescent wave associated with TIRF exists. The magnitude of the 
penetration depth, ', associated with the evanescent wave may be estimated using the equation  ?ൌ ߣ ?ߨට݊௚ଶݏ݅݊ଶߠ െ ݊௪ଶ  
where ݊௚ is the refractive index of the glass coverslip, ݊௪ is the refractive index of the sample and O 
is the excitation wavelength. In this case, ' is a decreasing function of the angle of incidence, T, and 
is typically 100-200 nm.   
2.4.2 TIRF Safety Considerations 
With respect to safety, it is important to fully enclose the excitation path to avoid exposure. In 
addition, we make use of black laser curtains surrounding the optical bench, and both a laser interlock 
ĂŶĚ  ‘ůĂƐĞƌ ŝŶƵƐĞ ?ǁĂƌŶŝŶŐƐŝŐŶ ƚŽ ŝŶĨŽƌŵŽƚŚĞƌƐ ƚŚĂƚ ƚŚĞǇŵƵƐƚ ƚĂŬĞŶĞĐĞƐƐĂƌǇƉƌĞĐĂƵƚŝŽŶƐďĞĨŽƌĞ
entering the area. Appropriate laser safety goggles should be worn and any laser shutters should be 
kept closed when the excitation source is not required. Finally, one should never look directly into the 
light path when the shutter is open. 
2.5 Stepwise Photobleaching Data Acquisition: A general imaging protocol to determine 
oligomer stoichiometry.  
The data we collect from the objective-based TIRF system is integrated fluorescence intensities from 
non-specifically immobilized AE555 oligomers. Immobile oligomers were imaged in 25 x 25 Pm regions, 
and plots of fluorescence intensity generated as a function of position. For each field of view, 
fluorescence emission from ~150-200 immobilized oligomers were acquired in parallel over a time-
course of typically 30 s using an EMCCD integration time of 50 ms. To provide confidence that 
fluorescence signals were representative of single AE555 peptides or oligomers, varying concentrations 
(1  ? 10 pM) were added to the surface, resulting in a corresponding increase in the number of 
fluorescent spots per field of view as shown in Figure 9 and a four-fold decrease in the mean nearest-
spot separation distance.
 
Figure 9. Representative TIRF images of immobilized AE555 as a function of peptide concentration. Wide-field 
fluorescence images of AE555 immobilized onto a poly-l-lysine coated glass coverslip at concentrations of (a) 1 
pM, (b) 5 pM and (c) 10 pM. 
An excitation wavelength of 532 nm, and power of 2 mW, as measured immediately prior to entering 
the objective lens, was selected to promote dye photobleaching over the timescale of the 
measurement. Under these conditions, monomer signal-to-noise ratios were typically in the range 3-
5. Excitation was continued until fluorescence emission dropped to background levels and at the end 
of each 30 second collection period, >90 % of all fluorescent spots had completely photobleached. In 
order to construct fluorescence-versus-time trajectories from immobilized oligomers, the integrated 
point-spread function signals were extracted from the sequence of frames in the captured movie. On 
the first frame, we initially identify a spatially isolated oligomer or peptide by a Gaussian distributed 
fluorescence profile from a 9 x 9-pixel matrix. Each pixel was then corrected for the background signal 
and the 15 brightest pixel values within the matrix were summed to give the oligomer intensity at the 
specific time at which the movie frame was acquired. This process was then repeated for each 
oligomer and each time point in the movie. The time series of the summed and background-corrected 
pixel intensities then produced a fluorescence time trajectory from each oligomer, similar to the trace 
shown in Figure 2d. The number of fluorescent dyes (and thus peptides-per-oligomer) present in each 
fluorescence trajectory may then be determined by counting the number of discrete photobleaching 
events evident above the background signal. 
Baseline-subtracted photobleaching time traces displaying < 10 quantized steps were fitted with a 
hidden Markov model (HMM)[76] to extract the number of peptides-per-oligomer in a probabilistic 
manner. Recently, HMM has been applied to access discrete levels in protein-induced fluorescence 
enhancement time traces[77], differentiate between single-molecule FRET states[78-80] and to analyze 
multichromophore photobleaching trajectories[81, 82]. Briefly, HMM is a stochastic model that maps 
measured values to unobserved states. In this application, the fluorescence trajectories obtained from 
single AE555 oligomers were modelled as a sequence of up to 10 different intensity values and 
transitions between these states were defined as a photobleaching event. HMM utilizes the Viterbi 
algorithm[83] to find the most likely sequence of states given a set of data and corresponding transition 
probability matrix and emission probability functions. We used the HaMMY algorithm[76] to analyze 
each normalized AE555 trajectory. The majority of photobleaching traces displayed exponential 
kinetics, meaning the final photobleaching step in the trajectory generally lasted longer than previous 
steps, and thus fitting of the last step had the greatest data support. The method was applied to the 
processing of all experimental stepwise photobleaching trajectories to extract the true number of 
states. Representative trajectories and reconstructed HMM fits are shown in Figure 10. By using the 
HMM model the number of peptides-per-oligomer were then extracted based on the goodness-of-fit 
and used to construct 1D population distribution histograms from an entire data set.  
 Figure 10. Representative single-molecule stepwise-photobleaching trajectories and reconstructions obtained 
from immobilized AE555 oligomers. Normalized variation in the fluorescence emission intensity obtained as a 
function of time from immobilized AE555 complexes displaying (a) a single photobleaching event, (b) two 
photobleaching events, (c) five photobleaching events and (d) six photobleaching events corresponding to the 
presence of a monomer, dimer, pentamer and hexamer, respectively. Solid green lines correspond to the 
experimentally measured data and solid black lines correspond to the idealized trajectories obtained via the 
HMM model.  
2.6 Optimization of Imaging Conditions  
It is important to note that wide-field single-molecule fluorescence detection does not discriminate 
between oligomers non-specifically bound to the substrate or fluorescent impurities attached to the 
glass or in the solvent. It is therefore important to evaluate the inherent background fluorescence 
within pre-cleaned and passivated microchannels prior to starting any experiment.  Impurities in the 
cleaning agents or buffers are typically the cause of high background levels and no more than 1-2 
adsorbed fluorescent species per 25 x 25 Pm field of view should be observed prior to the injection of 
the sample. If a high number of fluorescent spots are observed, then all buffers and solvents should 
be imaged to check for fluorescent impurities.  
AE oligomerization is known to be extremely sensitive to small variations in the environmental 
conditions[24, 25] and therefore the choice of aggregation buffer conditions are critical to consistently 
obtain reproducible results. The acceleration of AE oligomerization has already been observed at the 
interface of biomimetic membranes, and lipid rafts[84], and it has been suggested that when interfaced 
with highly fluorinated compounds, similar to HFIP, oligomers associated with the appearance of 
cognitive problems[85] are formed. Importantly the buffer conditions are also chosen to enable 
oligomer binding to the poly-l-lysine surface, and minimize any unwanted time-dependent changes to 
the dye photophysics. For these experiments, pH regulation is also essential, as it has been shown that 
exposure of AE to slightly acidic conditions accelerates the formation of higher order species.  
2.7  Data Interpretation. A case study on the evolution and inhibition of AE555 oligomers. 
A sample data set that we obtained from the stepwise photobleaching assay is shown in Figure 11. In 
essence, each 1D histogram shows the frequency of oligomeric AE555 species within a given set of 
environmental parameters. In the absence of HFIP, a freshly prepared 10 pM AE555 solution in 50 mM 
Tris buffer (pH 8.0) deposited directly onto a poly-l-lysine surface displayed probability densities of 
0.56 ± 0.11 corresponding to monomeric species (one-step bleaching) and 0.33 ± 0.06 corresponding 
to the presence of dimers (two-step bleaching). Only a small fraction of trimers and higher-order 
oligomers were observed by comparison (Figure 11 a). This distribution is in good agreement with that 
reported for FAM-labelled AE(1-40) in PBS buffer at pH 7.4, and serves to demonstrate that even under 
conditions considered to be  ‘ŶŽŶ-ĂŐŐƌĞŐĂƚŝŶŐ ? (i.e. lacking an aggregation catalyst), a distribution of 
monomers and low-order oligomers rapidly form and must therefore be properly accounted for in any 
subsequent analysis. It is important to note that control experiments indicate that surface-bound poly-
l-lysine nor base buffer influences the distribution of the species over the course of 5 h after 
preparation. To investigate the potential of the stepwise photobleaching method to monitor the time-
dependent oligomerization of AE555, we next explored the fluorescence response from the labelled-
peptides under experimental conditions known to promote globular oligomers.  In this case, the 
addition of 1.5 % (v/v) of HFIP to a freshly-prepared solution of 10 pM AE555 in 50 mM Tris buffer (pH 
8) induced a progressive decrease in the overall number of monomers, and a progressive increase in 
the number of oligomers over the course of 1 hour (Figure 11 b, c). One of the advantages of the 
stepwise photobleaching approach is that the growth of AE555 oligomers can also be identified by 
changes in the intensity distribution obtained from immobilized peptides and oligomers. For example, 
Figure 11 d shows the intensity distribution from individual AE555 complexes at the beginning and end-
point of the oligomerization process. As expected, the intensity distribution is shifted to higher values, 
indicating an increase in the relative abundance of oligomerized species.  The reproducibility of the 
assay was confirmed by performing three replicates using different AE555 preparations. 
 
 
 
Figure 11. Distributions of AE555 monomers and oligomers under varying sample conditions, as determined by 
single-molecule stepwise-photobleaching and intensity analysis. The number of peptides per fluorescent spot 
as determined by HMM analysis as a function of environmental condition are shown. Distributions were 
obtained from a freshly prepared sample of 10 pM AE555 in (a) 50 mM Tris buffer (pH8) and (b) after injection of 
1.5 % (v/v) HFIP after 15 min and (c) 1 h. (d) Representative AE555 intensity histograms are shown at the beginning 
(top panel) and end stage (bottom panel) of the oligomerization process.  As expected, the oligomerized AE555 
sample has an intensity distribution shifted towards higher values than for the freshly prepared sample. (e) Also 
shown are the number of peptides-per-oligomer observed for a 10 pM sample of AE555 in the presence of 1.5 % 
(v/v) HFIP and the oligomer inhibitor BSA (1 PM) after 1 h incubation. Data shown in (a-c and e) is expressed as 
the mean ± the standard error of the mean from three experimental runs. The histograms in (a), (b), (c) and (e) 
were constructed from a total of 6808, 1333, 4308 and 1631 fluorescent spots, respectively. 
To test the ability of the stepwise photobleaching method to report the interaction between AE and 
inhibitory agents, we investigated the effect of bovine serum albumin (BSA) as a model system. BSA is 
the most abundant protein found in mammalian serum and while its primary function is to transport 
various ligands, mounting evidence also supports a role as a molecular chaperone to prevent the 
misfolding and aggregation of amyloidogenic proteins[86, 87]. With respect to AE, BSA has displayed 
strong inhibition of the fibrillization process[86, 88] and was used in this work to explore its inhibitory 
potential towards HFIP-induced oligomers. As shown in Figure 11 e, a 10 pM AE555 sample incubated 
with 1 PM BSA was predominantly monomeric even after 1 h in the presence of 1.5 % (v/v) HFIP.  To 
get a clearer picture of whether the sample population exhibited significant differences relative to 
freshly prepared AE555 in the absence of HFIP and BSA (Figure 11 a), we performed a two-way ANOVA 
on the population means with AE species and condition as factors. This analysis revealed that at the p 
= 0.05 level, the population means associated with 10 pM AE555 are not significantly different to the 
means observed after 1 hour in the presence of 1 PM BSA (F = 0.795, p = 0.438). This is expected taking 
into account that the relative difference in mean probability densities for the monomeric and dimeric 
forms are only 0.02 and 0.03, respectively.  
Taken together, these results demonstrate that stepwise photobleaching of the covalently attached 
dye in the monomer and aggregated forms can be easily determined, thereby providing a means to 
quantify variations in relative populations as a function of time or oligomerization conditions. Such 
differentiation is not possible using ensemble-based analyses or extrinsic probes that do not interact 
with monomeric and/or oligomeric forms of AE. This is important to note given several lines of 
evidence that suggest amyloid toxicity may not be directly related to the presence of single oligomers, 
but rather the ability of these objects to grow and dynamically exchange[89].  
2.8 Fluorescence assays for assessing cell viability and intracellular Ca2+ levels following exposure 
of cells to AE oligomers. 
The mechanisms linking AE to neuronal dysfunction and eventual cell death are under-explored and 
remain largely obscure[90]. However, the emergence of recent experimental evidence supporting a 
toxicity model in which different soluble AE oligomers formed at different stages of the self-assembly 
process induce membrane permeabilization prompted us to apply a ratiometric and intracellular 
calcium sensing strategy to test for oligomer activity. We hypothesise that oligomer-induced 
intracellular Ca2+ overload (or indeed reduction) could be a no-return signal that triggers neuronal 
death.   
The method utilizes low concentrations of the calcium-sensitive (kd = 0.14 PM) and cell-permeant 
fluorescent ratiometric indicator, Fura-2, containing an acetoxymethyl ester (AM) group. Cleavage of 
the AM moiety by cytoplasmic esterases traps the dye within cells. The indicator undergoes spectral 
shifts following Ca2+ binding, enabling free Ca2+ levels to be quantified within living cells[90]. Fura-2-AM 
is one of the most common ratiometric calcium indicators and has an emission peak at 512 nm. When 
free cytosolic Ca2+ binds, the excitation peak shifts from 380 nm to 340 nm, while the peak emission 
at 512 nm remains unchanged. By sequentially exciting Fura-2-AM at 340 nm and 380 nm, and taking 
the ratio of the emission intensities at each excitation wavelength, a measurement of the 
corresponding cytosolic Ca2+ concentration can be gauged if the ratio has also been calibrated against 
known free Ca2+ concentrations. Unlike many other ratiometric Ca2+ probes, Fura-2-AM was chosen in 
this work because it has a larger dynamic range and offers greater resistance to photobleaching.  
It is worth noting that single cell microscopy imaging is one setting in which Fura-2-AM has been 
extensively applied to enable the simultaneous measurement of Ca2+ response in numerous individual 
cells incubated with AE. In this regard, the treatment of Fura-2-AM loaded astrocytes with AE(25-35) 
fragments and serotonin has been shown to increase Ca2+ signalling[91], and recently AE(1-42) 
oligomers were found to aggravate the loss of store operated Ca2+ entry and increase the resting 
cytosolic Ca2+ concentration in aging neurons[92]. Increased AE(1-42) activity has also been measured 
in elevated glucose levels as detected via Fura-2-AM loaded rat neurons[93]. Moreover, Fura-2 
derivatives loaded into large unilamellar vesicles have been used to suggest a two-step mechanism of 
AE(1-40) induced membrane disruption, whereby initial pore formation precedes membrane 
fragmentation[94, 95]. However, although the presence of oligomeric species were typically reported 
via, for example, Western Blots, heterogeneity between oligomeric forms were not fully 
characterized.  Having established a platform from which to access heterogeneity within oligomeric 
populations via stepwise photobleaching in this work, we next measured the ratiometric fluorescence 
response of neuroblastoma cells loaded with Fura-2-AM in the presence of pre-characterized 
AEoligomers, as shown schematically in Figure 13.  
To assay the activity of freshly prepared oligomers, the following procedure should be adopted: 
 
1. Human or rodent neuroblastoma cells (we use the rat B104 cell line [96]) are maintained as 
ĂĚŚĞƌĞŶƚ ĐƵůƚƵƌĞƐ ŝŶ ƵůďĞĐĐŽ ?Ɛ ŵŽĚŝĨŝĞĚ ĞĂŐůĞ ŵĞĚŝƵŵ  ?DD ? ĐŽŶƚĂŝŶŝŶŐ ŐůƵƚĂŵŝŶĞ
supplementation (Thermo Fisher Scientific, UK, part number 11965084), 10 % (v/v) foetal 
bovine serum (FBS) and 100 U/ml penicillin/streptomycin (Thermo Fisher Scientific, UK, part 
number 15140122) in sterile 75 cm2 flasks (Corning, Germany, part number 430639) at 37°C, 
5 % CO2. The cells are passaged when confluent, usually every 2-3 days, by transferring a third 
of the cells to a new flask. 
 
2. The fluorescence imaging assays are conducted in a 96 well plate. To plate cells, they must 
first be detached from the flask and counted. Remove the DMEM media from the flask by 
pipette and gently wash the cells by replacing the media with 10 ml phosphate-buffered saline 
(PBS; 0.137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4)..  
 
Remove the PBS buffer by pipette and add 1 ml 0.025 % trypsin and 0.01% EDTA in PBS 
buffer to the flask (Thermo Fisher Scientific, UK, part number R001100). Return the flask to 
the incubator for 5 min. This step detaches the cells from the flask surface. After a maximum 
of 5 min, add 10 ml DMEM to the flask and remove the cell suspension to a 15 ml centrifuge 
tube. Pellet the cells by spinning at 1000 g for 5 min in a centrifuge.  
 
3. Remove the supernatant and resuspend the cell pellet in 1 ml of DMEM. To evaluate the cell 
density, apply a 20 PL sample from the cell suspension to a haemocytometer (VWR, UK, part 
number 631-0696). View the cells using a conventional phase contrast brightfield upright 
microscope (eg. Motic, UK, AE20 series) at room temperature. Count the number of cells in a 
0.1 x 0.1 mm2 area (equivalent to a volume of 0.1 mm3) and multiply by 10, 000 to obtain the 
number of cells / ml.  
 
4. Dilute the cells in DMEM to yield a concentration of 25, 000 / ml and apply 200 PL (5000 cells) 
to each well in a 96 well-plate (Corning, Germany, part number 3988). Place the plate in the 
incubator overnight. 
 
5. Prior to treating the cells, they are equilibrated in the assay buffer. Remove the culture media 
from each well and replace with 200 µL KREBS buffer (119 mM NaCl, 2.5 mM KCl, 1 mM 
NaH2PO4, 2.5 mM CaCl2.2H2O, 1 mM MgCl2.6H2O, 4 mM HEPES, 10 mM D-glucose, pH 7.4). 
Incubate the cells for 10 min at 37°C. 
 
6. To assay the effect of AE oligomers on cell viability, cells were treated for 2 h at 37°C in KREBS 
buffer containing 4-10 Pg/mL of AE(1-42) (unlabelled) or AE555 (labelled) in < 0.5 % (v/v) HFIP 
and < 1 % (v/v) DMSO, with 0.1 PM propidium iodide (PI) (Sigma Aldrich, UK, part number 
P4170). PI is a nuclear and chromosome fluorescent stain with excitation and emission 
maxima at 535 nm and 617 nm, respectively, when bound to DNA. PI is not membrane 
permeable in live cells, but intercalates between DNA bases with little dependence on 
sequence when membrane permeabilization occurs. The cells in the 96 well plate are imaged 
every few minutes over the 2 h incubation period. Imaging is conducted with an epi-
fluorescence microscope (eg. Nikon, Japan, part number TE200) using a 20 X objective (eg. 
Nikon, part number ELWD 20XO), 550 nm excitation filter (Chroma, USA, part number 
ET550/15x), 575 nm dichroic mirror (Nikon, Japan, part number G2-A DM575) and a 590 nm 
long pass emission filter (Nikon, Japan, G2-A, BAA590). Images are captured in brightfield and 
fluorescence modes using a CCD camera (eg. Rolera-XR, Q Imaging, Canada) with a 200 ms 
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ImageJ and cell viability determined by counting the number of dead cells displaying co-
localized regions of fluorescence occurring from PI stained nuclei. After 2 h incubation with 4-
10 Pg/mL of AE(1-42) (unlabelled) or AE555 (labelled), cell viability progressively dropped to < 
20 % (Figure 12), pointing towards a membrane permeabilization mode of action. Under 
control conditions, in which B104 cells were treated with KREBS buffer including 0.5 % (v/v) 
HFIP and 1 % (v/v) DMSO but lacking AE(1-42), no change to cell viability was observed over 
the course of 2 h (Figure 12). 
 
Figure 12. Propidium iodide staining in B104 cells. Nuclear morphological changes on treatment 
with (a) the absence and (b) presence of 2.5 Pg/mL AE(1-42) under oligomerization conditions (KREBS 
buffer, 0.5 % HFIP, 1 % DMSO) for 2 hours in B104 neuroblastoma cells were detected by propidium 
iodide staining and observed via fluorescence microscopy. The blue arrow indicates a live cell, whereas 
red arrows represent apoptotic cells with altered nuclei (shown in red). The scale bar indicates 5 Pm. 
7. To assay the dysregulation of intracellular Ca2+ by AE oligomers, cells are first incubated with 
0.1 PM Fura-2-AM (Thermo Fisher Scientific, UK, part number F1201) and 0.001 % pluronic 
acid in KREBS buffer for 20 min at 37oC. 
 
8.  After 20 min incubation, gently wash each well three times with 200 µl KREBS buffer at room 
temperature to remove any residual dye. After the third wash step, incubate the cells in KREBS 
buffer for 10 min at 37oC prior to treatment with AE oligomers and live cell imaging. 
 
9. Imaging was performed using the same microscope as specified in Step 6, with 340 and 380 
nm excitation filters (Chroma, USA, part numbers ET340x and ET380x), a 400 nm dichroic 
mirror (Chroma, USA, part number T400lp) and 510 nm band pass emission filter (Chroma, 
USA, part number ET510/80m) replaced. Images are acquired in brightfield and fluorescence 
modes, with the latter performed sequentially using excitation wavelengths of 340 nm and 
380 nm, respectively. Fura-2-AM fluorescence emission is collected at 510 nm, using an 
exposure time of 200 ms. Imaging is typically performed every 10 s over a time-window of 
1000 s after application of AE-containing KREBS buffer. 
 
10.  Image stacks containing fluorescence from Fura-2-AM under excitation of 340 nm and 380 
ŶŵĐĂŶďĞƉƌŽĚƵĐĞĚƵƐŝŶŐƚŚĞ ‘^ƚĂĐŬ ?ĨƵŶĐƚŝŽŶŝŶ/ŵĂŐĞ: ?Figure 13a). Cells that take up Fura-
2-AM are identified by comparing brightfield images with fluorescence images, and 
subsequently defined as regions of interest. Image stacks are then imported into Fiji and 
fluorescence trajectories per cell are determined using tŚĞ ‘dŝŵĞ^ĞƌŝĞƐŶĂůǇǌĞƌ ?ƉůƵŐŝŶ ? 
 
11.  The dysregulation of calcium homeostasis induced by AE is observed as an exponential 
increase in the ratio of the fluorescence emission intensity using 340 nm excitation and a 
corresponding decrease in fluorescence intensity 380 nm excitation (Figure 13b). Intracellular 
calcium dysregulation is typically observed immediately after application of pre-formed HFIP-
AE555 oligomers onto Fura-2-AM loaded cells, and followed via a single-exponential growth 
model with a kinetic rate constant of 0.028 ± 0.003 s-1 (F2 = 0.97) (Figure 13c).  We note that 
a limitation to Fura-2-AM, as with most Ca2+ indicators, is that it cannot be specifically targeted 
to intracellular organelles. However, recent advances in probe designs have seen the 
development of mitochondrial-specific derivatives of Fura-2[97], and these may be valuable 
given the strong body of evidence linking AE with mitochondrial dysfunction[98]. Nevertheless, 
the absolute concentration of free calcium per cell, C, at each time point, can be related to 
the dissociation constant via the expression ܥ ൌ ݇ௗ ሺܴ െ ܴ௠௜௡ሻሺܴ௠௔௫ െ ܴሻ ܫ௙ܫ௕ 
where R is the ratio of the fluorescence emission obtained under 340 and 380 nm excitation, 
respectively. The values of Rmax and Rmin are the ratio values measured under conditions of 
saturating calcium levels and the absence of calcium, respectively. If and Ib are the 
fluorescence emission intensities of free and bound Fura-2 obtained using 380 nm excitation. 
In essence, this procedure assays a sequence of events whereby AE-induced membrane 
permeabilization promotes an imbalance in intracellular Ca2+ levels preceding neuronal death. Since 
dysregulation in Ca2+ homeostasis is observed long before the onset of the first symptoms of AD, this 
relatively straightforward protocol may offer possibilities for evaluating the rate of Ca2+ dysregulation 
as a function of oligomeric morphology, and may even be extended to evaluating the effects on 
peripheral cells such as fibroblasts and lymphocytes, offering a far greater understanding of the role 
of AEoligomers in AD pathogenesis. A proper understanding of the complexity of Ca2+ signalling clearly 
requires careful evaluation of the applied scientific approach, and the knowledge acquired from this 
protocol, does not allow one to categorically state whether alterations in Ca2+ homeostasis are the key 
and primary event in AD, or whether they simply accompany the AD pathway. It should also be noted 
that this protocol is discussed in the context of understanding AE toxicity under controlled conditions 
and this may be indistinct from the pathology observed in the brain of an AD patient. Nevertheless, it 
is clear that instabilities in Ca2+ homeostasis appear early in AD pathogenesis, and the presented 
strategy may at least have some relevance to the disease process, and we expect the approach could 
ultimately aid basic science methods aimed at correcting or slowing AE-induced dysregulation of Ca2+ 
homeostasis. 
 
 
Figure 13. The process of data collection and analysis for determining AE-induced Ca2+ dysregulation in B104-
neuroblastoma cells. (a) Wide-field fluorescence images of Fura-2-AM loaded cells obtained with excitation 
wavelengths of 380 nm and 340 nm are taken over time and recorded as image stacks. In each movie frame, 
corresponding pairs of regions of interest are identified. (b) Each pair in each movie frame gives the fluorescence 
intensities, I380 and I340, associated with Fura-2-AM emission. A time-trajectory of the fluorescence emission 
intensities is used to generate the Ratio of emission intensities, R, as a function of time. (c) Representative wide-
field fluorescence image of Fura-2-AM loaded B104 neuroblastoma cells (Oex = 340 nm) at 200 s after application 
of 2.5 Pg/ mL pre-formed AE555 oligomers. Detailed descriptions can be found in the main text. Also shown is 
the mean R response from 30 cells after AE application. Error bars represent the standard error of the mean. 
 
3. Conclusions and Outlook 
As evident from our results and others, single-molecule stepwise photobleaching measurements can 
provide unprecedented levels of detail and insight into the stoichiometry of single immobilized AE 
oligomers, providing important insight in particular when correlated with ratiometric information 
which details oligomer activity. By utilizing AE(1-42) labelled at the N-terminal position with a 
fluorophore, we have demonstrated that the population distributions of oligomers, as well as their 
time-dependent evolution, can be easily accessed, overcoming several limitations associated with 
traditional sensing methods involving extrinsic probes. Importantly, the technique not only constitutes 
a powerful and straightforward approach to quantify the size distribution of single oligomers in 
solution, but also provides a quantifiable metric to ensure that samples of starting AE material are 
identical. This is a crucial feature to avoid common discrepancies observed with in vitro studies of AE 
aggregation caused by heterogeneity between freshly prepared samples[99]. While the use of intrinsic 
probes are not completely free from interference limitations, they offer interesting advantages over 
the use of extrinsic probes. Since in this case HiLyte Fluor 555 is covalently linked to the AE monomer 
at the N-terminus, the identification of oligomeric species is not limited by the formation of probe-
specific binding sites or by any variations in the affinity of the extrinsic probe. Moreover the use of an 
intrinsic probe potentially eliminates competition between extrinsic probes and inhibitor compounds 
for binding sites, however, as with any fluorescence-based assay, care must be taken to ensure that 
any alterations of the fluorescence properties of the intrinsic probe are not due to specific interactions 
with the inhibitor. There are of course obvious limitations to the use of N-terminal labelling for certain 
applications. For instance, the requirement to employ synthetic peptides makes difficult its 
implementation as a diagnostic tool, and while there is evidence to suggest that N-terminal tagging 
with HiLyte Fluor 555 and others does not perturb aggregation rates or the final surface-immobilized 
aggregated structures[24, 100, 101], it is important to note that we cannot rule out that the immobilized 
AE activity is different from the native form. Nevertheless, experimental tools capable of accessing 
oligomer stoichiometry are critical for a full understanding of the environmental factors which govern 
their growth and stability, and although the stepwise photobleaching method at the current time is 
only applicable to controlled experimental conditions devoid of contaminants and solutions with 
complex composition, we expect it may be useful for the rational screening of novel anti-
oligomerization inhibitors in vitro. Moreover, by evaluating the kinetic rate of AE-induced 
dysregulation of intracellular Ca2+ homeostasis, we have demonstrated a ratiometric approach to 
quantify the oligomeric activity. Taken together, the approaches presented enable direct 
characterization of the earliest stages of AE(1-42) self-assembly and toxicity to be accessed, bypassing 
major limitations associated with conventional sensing strategies. More generally, the 
implementation of correlative single-molecule based techniques represents a complementary 
approach for the real-time interrogation of AE self-assembly and toxicity mechanisms and is an 
attractive alternative to the use of extrinsic probes when rationally screening for oligomerization 
inhibitors. We expect the methods presented here will facilitate investigating the mechanisms of AE 
oligomerization under controlled conditions, and consequently how the growth and toxicity of 
transient species may be regulated by local environmental variables such as pH and temperature. We 
also expect the methodology to be extended to the investigation of aggregation processes associated 
with other miƐĨŽůĚĞĚƉĞƉƚŝĚĞƐŝŵƉůŝĐĂƚĞĚŝŶǀĂƌŝŽƵƐƉĂƚŚŽůŽŐŝĞƐ ?ŝŶĐůƵĚŝŶŐƚĂƵŝŶůǌŚĞŝŵĞƌ ?ƐĚŝƐĞĂƐĞ
and D-ƐǇŶĐƵĐůĞŝŶŝŶWĂƌŬŝŶƐŽŶ ?ƐĚŝƐĞĂƐĞ ?
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